News

Insider Monkey on MSN4h

MannKind (MNKD) Secures $500M Financing to Advance Inhaled Therapies Pipeline

We recently published 12 Best Healthcare Stocks to Buy Under $30. MannKind Corporation (NASDAQ:MNKD) is one of the best ...

MannKind (MNKD) Q2 Revenue Rises 6%

MannKind (NASDAQ:MNKD), a biopharmaceutical firm known for its inhaled insulin and pulmonary therapeutics, released its second quarter 2025 earnings on August 6, 2025. The most si ...

MannKind and Blackstone Announce up to $500 Million Strategic Financing Agreement

MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products and delivery devices for patients with endocrine and orphan lung ...
Pacific Coast Business Times6d

MannKind inks $500M financing agreement with Blackstone

Westlake Village-based MannKind Corporation is receiving some extra help to advance some of its short and long-term growth strategies. Announced Aug. 6, MannKind, a biotech company focused on inhaled ...